Patient-reported outcomes in patients with metastatic castration-resistant prostate cancer and BRCA1/2 mutations receiving first-line niraparib with abiraterone acetate plus prednisone (Magnitude study) Meeting Abstract

  

Authors:	Nguyen, C.; Rathkopf, D. E.; Chi, K. N.; Small, E.; Smith, M.
Abstract Title:	Patient-reported outcomes in patients with metastatic castration-resistant prostate cancer and BRCA1/2 mutations receiving first-line niraparib with abiraterone acetate plus prednisone (Magnitude study)
Meeting Title:	49th Annual Congress of the Oncology Nursing Society (ONS)
Journal Title:	Oncology Nursing Forum
Volume:	51
Issue:	2
Meeting Dates:	2024 Apr 24-28
Meeting Location:	Washington, DC
ISSN:	0190-535X
Publisher:	Oncology Nursing Society (ONS)
Date Published:	2024-03-01
Start Page:	18
End Page:	19
Language:	English
ACCESSION:	WOS:001349389400123
PROVIDER:	wos
DOI:	10.1188/24.ONF.E3
Notes:	Meeting Abstract: I34 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/222028